Dasatinib, Temsirolimus, and Cyclophosphamide in Treating Patients With Advanced, Recurrent, or Refractory Solid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Emory University
Augusta University
Universitätsklinikum Hamburg-Eppendorf
St. Jude Children's Research Hospital